WHA
Click for more information
0.00% 48.7¢ wattle health australia limited

Executive Series 26 Jun 18: Wattle Health Australia (WHA) CEO, Lazarus Karasavvidis, page-61

  1. 8horse
    26,847 Posts.
    lightbulb Created with Sketch. 1841
    clock Created with Sketch.
    27/07/18
    15:53
    Post #: 34597800
    Not about the $50m cash, it's about SMRA/CFDA approval (passed technical review) and two signficiant sale agreements upong SMRA/CFDA approval.
    And Organic powder dryer facility and organic infant formula development, goat infant formula...

    Further to our announcement of 6 April 2018, WHA has passed technical evaluation for State Administration for Market Regulation (SAMR, formerly known as CFDA) accreditation for China. WHA is now waiting for formal approval and attainment of SAMR, on receipt of which revenue is projected to reach in excess of $140 million over a 42-month period in the China market
    WHA Price at posting: $1.53 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
watchlist Created with Sketch. Add WHA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.